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The 56-kb ocfC gene cluster is required for occidiofungin production by
Burkholderia contaminans strain MS14. However, the function of the ocfC gene remains
unknown. Sequence analysis showed the putative protein encoded by ocfC shares
significant identities to glycosyltransferase. Plate bioassays showed that occidiofungin
production by the ocfC mutant (ocfC::nptII) was significantly reduced as compared with
strain MS14. The occidiofungin produced by the ocfC mutant is xylose-free, which
suggests the ocfC gene encodes a xylosyltransferase to add a xylose to the peptide
backbone. Single variant optimization of culture condition and medium compositions was
also performed in this study. The results indicated that occidiofungin production was
promoted with higher cell density inoculum, additional casamino acid, xylose, urea, zinc
ions, and at pH 5. The findings have provided insights into development of
pharmaceutical drug and agricultural biofungicide.
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CHAPTER I
GENERAL INTRODUCTION

Biological control
Biological control is the use of natural or modified organisms, genes, or gene
products to reduce the effects of undesirable organisms such as plant pathogens and to
favor desirable organisms such as crops (5). Classical biological control, referred to as
bio-control, can be categorized into three strategies (22). First, regulation of pest
population is to manage pest population at or under an acceptable population level.
Second, exclusionary systems of protection use beneficial microorganisms to prevent
infection or pest attack. The third, systems of self-defense, is used when regulation or
pest population and exclusionary systems of protection are not possible. This strategy
could enhance self- defense in the plant that could limit disease severity or pest damage
(22).
Three bio-control agents are described by Cook as follows (22). First, the pest or
pathogen is applied against itself. For example, sterile males or modify the behavior of
insects with pheromones was released to regulate the population (Strategy 1). Second,
antagonists or enemies of pest or disease agents are used to exclude the pest or pathogen.
For instance, using rhizobacteria provides an exclusionary system of protection from
target pathogens (strategy 2) (5). One well-known example of this is Agrobacterium
1

radiobacter strain K84 for bio-control of crown gall caused by Agrobacterium
tumefaciens (21). Last, host plants are managed or manipulated to defend themselves.
Plants can be managed culturally or genetically in order to maximize the physiological or
biological systems of self-defense of the plant (Strategy 3).
According to Herrera- Estrella and Chet, there are several mechanisms to apply
bio-control of plant disease (11). The first mechanism is to induce resistance and crossprotection of the plant. de Wit stated that susceptible plant response to challenge by
microorganisms or abiotic agents is the way to induce resistance. He also mentioned that
cross-protection is to follow the inoculation with an avirulent or weak strain of pathogen
(7). After that, both the pathogen and inducing microorganisms will survive in the plants.
Application of a weak strain of Fusarium oxysporum f. sp. vasinfectum is one of the
examples of cross-protection against pathogenic Fusarium oxysporum f. sp. vasinfectum
(12). The second mechanism is hypovirulence, defined as a strain of pathogen with
reduced virulence. A hypovirulent strain of Cryphonectria parasitica was used against
chestnut blight (1). Third, competition happens when space or nutrition is limited. For
example, there would be bio-control agent near the root may protect it by using space and
nutrition resources and making them unavailable to a pathogen. Fourth, an antibiotic is a
compound to inhibit the growth of a pathogen. For instance, zwittermicin produced by
Bacillus cereus UW85 can be used for bio-control agent for Phytophothora root blight
(24). Fifth, antibiosis is antagonism with metabolites of fungal antibiotics or antibioticlike compounds or some toxic compounds (10). Last, bio-control has some advantages
over chemical pesticides for soilborne disease. Pseudomonas fluorescens has been used
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for soil-borne disease management because of its ability to colonize roots and produce
antifungal metabolites (13,15).

Optimization of antifungal compound production
Antifungal compounds produced by bacteria may be used as biological control
agents. However, the production of antifungal compounds in standard culture conditions
is relatively low. Optimization of the antifungal compound production is routinely used
for increasing the yields of these compounds. For example, iturin A is a kind of
lipopeptide antibiotic produced by Bacillus subtilis RB14-CS that showed antagonistic
activities against some plant pathogens (19). Solid-state fermentation (SSF) with soybean
residue was used to optimize the production of iturin A. By using SSF, the production of
iturin A reached 3,300 mg/kg, about a ten-fold compared to the original method (19). By
using experimental design to find out the combination of 0.998g per wet okara glucose
and 1.83g per wet okara soybean meal, the concentration of iturin A was 5,591 mg/kg
(20). Cyclosporin A, a cyclic antibiotic, is produced by Tolypocladium inflatum MTCC
557 (3). It showed not only immunosuppression but also antifungal activities. Solid state
fermentation was used to enhance the production of Cyclosporin A so that the
concentration of Cyclosporin A was five times that of the traditional culture method (25).
Carnobacteriocins produced by Carnobacterium maltaromaticum CP5 are potential food
preservative agents (14). Heterologous expression in Escheridia coli was used to
optimize the production of carnobacteriocins from 100 µg/L to 320 mg/L.
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The Burkholderia bacteria
The genus Burkholderia used to be part of the genus Pseudomonas. In 1992,
Yabuuchi et al. split a few species in Pseudomonas by rRNA group II to form the new
genus Burkholderia with B. cepacia as the type species (28). In general, the 16S rDNA
sequence is used to differentiate the bacteria (27). However, the sequence for the recA
gene is used to differentiate the Burkholderia bacteria to species level. This is because
16S rDNA could not provide enough sequence variation to differentiate some
genomovars of Burkholderia (23).
The bacteria Burkholderia bacteria exist in water, soil, and the rhizosphere. These
Burkholderia could be potential bio-control, bio-mediation, and plant-growth-promoting
agents. However, some of the Burkholderia bacteria are also opportunistic pathogens of
human cystic fibrosis patients (23). For this reason the U.S. Environmental Protection
Agency (EPA) had prohibited the further application of Burkholderia (23). Therefore,
understanding these bacteria at the molecular level might provide important clues to
applying antifungals as potential human and animal drugs.

Burkholderia contaminans
Burkholderia contaminans is a species discovered as a sample contaminant (18).
B. contaminans strains are Gram-negative, aerobic, non-sporulating rods. Colonies on the
plates are moist and most strains show yellow pigment. It is reported that this bacterium
could grow at 30, 37 and 42 °C and its G+C content is 67% (26). These strains are mostly
isolated from clinical samples and some strains are from natural environments. The type
strain J2956 was found from sheep milk in Spain (2).
4

The ocf gene cluster
The ocf gene cluster was identified from Burkholderia contaminans strain MS14
and also existed in other strains such as Burkholderia ambifaria strain AMMD (8). The
size of whole gene cluster is 56 kb and 16 ORFs (or genes) were identified (Fig. 1.1) (8).
The genes ambR1 and ambR2 encode two LuxR regulatory proteins (9). The genes ocfD,
ocfE, ocfF, ocfH, and ocfJ encoded non-ribosomal peptide synthetases and are required
for biosynthesis of occidiofungin (9). The ocfA gene was predicted to code for an ATPbinding cassette (8). The ocfC, ocfK, ocfL, ocfM, and ocfN genes were predicted to be
involved in modification of occidiofungin (8).

Occidiofungin
Occidiofungin (fungus killers) is an antifungal compound produced by
Burkholderia contaminans strain MS14 (16). It was a cyclic glycopeptide made up of
eight amino acids and one xylose (16). Four variants, named as occidiofungin A, B, C
and D have been identified from the MS14 strain culture (Fig. 1.2) (8). Occidiofungin
inhibits the growth of a broad range of fungal pathogens and its mode of action was
predicted to be disruption of biosynthesis of the fungal cell wall (17). The compounds
have shown the great potential for pharmaceutical and agricultural applications.

Glycosyltransferase
Glycosyltransferase is a group of enzymes which catalyzes the transfer of a
monosaccharide unit from a glycosyl donor to a glycosyl acceptor molecule.
5

Classification of glycosyltransferase is based on the amino acid sequence similarities
except in families 19, 22, 24, 25 and 26 (4). In 1997, 26 glycosyltransferase families were
found based on this classification. However, since the sequence of genomes for
eukaryotes organism, the growth of glycobiology, and the extension of integrated
glycosyltransferase, the number of the glycosyltransferase sequences has increased
enormously(6). Currently, there are 94 families for glycosyltransferases based on the
carbohydrate-active enzymes (CAZy) database (http://www.cazy.org/). Many
glycosyltransferases have not been well studied. For Burkholderia ambifaria AMMD,
there are 79 sequences for glycosyltransferase. Of these there are 19 ORFs in family 2
and 24 ORFs in family 4. For Burkholderia glumae BGR1, there are 69 known
glycosyltransferase sequences with 21 sequences belonging to families 2 and 4. Thus, for
Burkholderia ambifaria AMMD and Burkholderia glumae BGR1, the majority of the
glycosyltransferases belong to families 2 and 4.

Significance of the study
Burkholderia contaminans MS14 isolated from a soil in Mississippi (17)
produced the glycopeptide antifungal compound occidiofungin (8, 16).
This study focuses on the function of one of the genes in ocf gene cluster, the
ocfC gene, which is predicted to add xylose to oligopeptide to form occidiofungin. This
study also shows that optimization of medium components and culture conditions can
promote occidiofungin production by novel strain MS14. Findings of this work provide a
solid basis for further studies to enhance the compound production by genetic
manipulations and optimization of culture conditions and medium components. Mass
6

production of the antifungal compound will be extremely useful for further studies of this
compound as a pharmaceutical drug and as an agricultural biofungicide.
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Figure 1.1 Map of 56-kb occidiofungin gene cluster of Burkholderia contaminans strain
MS14 (8)
Horizontal arrows indicate the positions and orientation of the known genes. The
insertion positions of the Tn5 transposon and the nptII gene cassette are showed as
vertical arrows and flags, respectively. Reduction and elimination of antifungal activity
are presented as the open and solid vertical arrows and flags, respectively.
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Figure 1.2 Structure of occidiofungins
Monoisotopic masses for occidiofungin variant A to D are listed and the location of each
variant designated by R1 and R2 (8).
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CHAPTER II
FUNCTIONAL CHARACTERIZATION OF THE OCFC GENE IN OCCIDIOFUNGIN
PRODUCTION BY BURKHOLDERIA CONTAMINANS STRAIN MS14

Abstract
Burkholderia contaminans strain MS14 shows a significant level of antifungal
activity. In previous studies, a 56-kb ocf gene cluster was determined to be essential for
occidiofungin production. In this study the ocfC gene, which is located downstream of
ocfD and upstream of ocfB gene in the ocf gene cluster, was examined. The antifungal
activity of the ocfC gene mutant MS14KC1 was significantly reduced against the
indicator fungus Geotrichum candidum compared with the wild type strain, which
indicates a functional ocfC gene was important for occidiofungin. Furthermore, the
analyses of the protein sequence and the chemical structure of occidiofungin produced by
MS14KC1 reveals that the ocfC gene encodes a xylosyltransferase. Possible functions of
the ocfC gene in occidiofungin production were discussed.
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Introduction
Members of the bacteria Burkholderia exist naturally in environments such as
water, soil, and the rhizosphere of crop plants (17). Some Burkholderia bacteria show
striking efficacy in controlling fungal diseases of crops as biological control agents for
plant disease management (4). However, the application of Burkholderia bacteria was
prohibited because of difficulty differentiating taxonomically these beneficial strains
from the Burkholderia strains that are opportunistic pathogens associated with the human
disease cystic fibrosis (17). Understanding the molecular mechanisms of antifungal
activities of the Burkholderia strains will provide important clues for the development of
biologically based fungicides while eliminating potential health risks.
Genetic analysis revealed that a 56-kb ocf gene cluster is required for production
of antifungal activity by Burkholderia contaminans strain MS14. Strain MS14 showed a
broad range of antifungal activity to plant and human fungal pathogens (14). A
glycopeptide, occidiofungin, produced by strain MS14 is responsible for its antifungal
activity (9,13). Sixteen genes have been predicted in the ocf gene cluster, including the
genes encoding nonribosomal peptide synthetases (ocfD, ocfE, ocfF, ocfH, and ocfJ), the
bacterial LuxR regulatory proteins (ambR1 and ambR2), and an ATP-binding cassette
(ocfA) (9). Mutagenesis and sequence analysis revealed that these genes are associated
with occidiofungin production by strain MS14. However, functions of the remaining
genes including ocfC had yet to be studied regarding their contribution to occidiofungin
production.
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Glycosyltransferases (GTs) (EC 2.4.1.-) are the enzymes that catalyze the transfer
of a monosaccharide unit from an activated nucleotide sugar, also known as the "glycosyl
donor", to a glycosyl acceptor molecule such as alcohols or oligopeptides (3).
Glycosyltransferases have high donor and acceptor substrate specificities and form one
glycosidic linkage (2). Classification of glycosyltransferase is based on the amino acid
sequence similarities except families 19, 22, 24, 25 and 26 (3). In 1997, 26
glycosyltransferase families were found based on this classification (3). However, due to
the sequencing of genomes for eukaryotic organisms, the growth of glycobiology and the
extension of integrated glycosyltransferase, the number of known sequences encoding
glycosyltransferase have increased enormously (5). According to the carbohydrate- active
enzymes (CAZy) database (http://www.cazy.org/), there are 94 families for
glycosyltransferases and many glycosyltransferases have not been well studied.
The Burkholderia contaminans MS14 glycosyltransferase OcfC is predicted to
enable the addition of xylose on the occidiofungin and belongs to the GT25 family,
which is a family involved in lipooligosaccharide (LOS) biosynthesis, such as Lgt2 of
Moraxella catarrhalis and Lic2A of Haemorphilus influenza for beta- (1,4)
galactosyltransferase (8,15). According to the CAZy database, the Arad_3667 protein of
Agrobacterium radiobacter K84 (21), the EcolC_3376 protein of Escherichia coli ATCC
8379, the MCA1423 protein of Methylcoccus capsulatus str. Bath(25), the Xccb100_0220 protein of Xanthomonas campestris pv, campestris (24), and the PXO_04234
protein of Xanthomonas oryzae pv. oryzae PXO99 (20) also belong to the GT25 family.
Occidiofungin has showed great potential as a biofungicide and medical drug
(13). Understanding the genetics and biosynthesis of this antifungal compound will
15

provide deep insights to optimizing the production by the host bacteria. A few genes of
the ocf gene cluster, such as ocfC, remain to be investigated. There is a xylose in the
occidiofungin molecule and preliminary sequencing analysis indicated the ocfC gene
codes for the putative glycosyltransferase (9). We hypothesized that the ocfC gene codes
for an enzyme to catalyze addition of xylose to the backbone peptide of occidiofungin. In
this study, the ocfC gene was disrupted with a nonpolar mutation and effects of the
mutation on occidofugin production were evaluated. Possible functions of the ocfC gene
are discussed.

Materials and methods

Bacterial strains, plasmids and media
Bacterial strains and plasmids used in this study are listed in Table 2.1.
Escherichia coli JM109 (Promega, Madison, WI) was used in cloning and was cultured at
37°C on Luria-Bertani (LB) agar. Nutrient broth-yeast extract (NBY) agar media (23)
were used to culture Burkholderia contaminans strain MS14 at 28°C . Potato dextrose
agar (PDA) (Difco, Detroit, MI) and Burkholderia minimum media (BM) (26) were used
for antifungal activity assays. Antibiotics (Sigma Chemical Co., St. Louis, MO) were
added to media at the following concentrations: ampicillin (100 µg/mL), kanamycin (100
µg/mL for E. coli and 300 µg/mL for the MS14 mutants) and trimethoprim (50 µg/mL).
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DNA isolation and manipulation
®
The cetyl trimethyl ammonium bromide protocol (7) or Wizard Genomic DNA

Purification kit (Promega Corporation, Madison, WI) was used for extraction of bacterial
genomic DNA. Primers were synthesized by Integrated DNA Technologies Inc.
(Coralville, IA) and Eurofins MWG Operon (Huntsville, AL). Plasmid extraction was
done using the QIAprep® Spin Miniprep kit (QIAGEN Inc., Valencia, CA). Wizard® SV
Gel and PCR Clean-Up System kit (Promega) was used to recover DNA fragments for
cloning. Sequencing was sent to Eurofins MWG Operon. Phylogenetic analysis was
conducted using MEGA4 (22).

Mutagenesis of the ocfC gene
Primers 6471R1649 (5’- GCCTACCTGCGCGTCTATCA) and 6471F137 (5’CCATGGCGGCGATTTGCTTTGA) were designed in order to amplify the ocfC gene by
polymerase chain reaction (PCR). The final concentrations of PCR reagents in the 50 l
reaction were: MgCl2, 2 mM; dNTPs, 0.4mM; primers, 0.6mM each; Taq DNA
polymerase, 0.75 units. The PCR cycling conditions were 4 min at 95°C, then 50 s at
95°C, 50 s at 56°C and 2 min at 72°C for 30 cycles, followed by 8 min at 72°C. The PCR
amplicon containing the ocfC gene with the flanking regions was cloned into the vector
pGEM-T Easy (Promega) to generate the plasmid pKC1. Plasmid pBSL15 was partially
digested with EcoRI and then self-ligated to remove the restriction endonuclease EcoRI
digestion site as described previously (11). A 1.3-kb PstI fragment of the plasmid
pBSL15 lacking EcoRI site and carrying the non-polar kanamycin cassette (the nptII gene
fragment) was cloned into the ocfC gene of the plasmid pKC1 using a PstI partial
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digestion strategy. The resulting plasmid pGEM-T Easy-ocfC::nptII was named pKC2.
The ocfC::nptII DNA fragment was introduced to the EcoRI site of the vector pBR325
(18) to generate plasmid pKC3. Plasmid pKC3 was electroporated into cells of the wild
type MS14 for marker exchange mutagenesis (C=25µ, 200Ω, v=1.8KV, and cuvette
1mm). NBY media containing kanamycin (300 µg/mL) were used for selection of the
mutants. PCR amplification and sequencing were used for confirmation of double
crossover mutagenesis. Plate bioassays were used to evaluate the production and
biological activity of occidiofungin as described (11).

Results

Sequence analysis of the ocfC gene
The ocfC gene is located downstream of the ocfD gene and upstream of the ocfB
gene in the ocf gene cluster (9-11). No significant promoter region or terminator was
identified from the 5’ and 3’ termini of the ocfC gene. The 657 base-paired ocfC gene
was predicted to code for a 218-residue putative protein which was predicted to be the
glycosyltransferase that presumably catalyzes the transfer of a xylose to the C-7 site of
occidiofungin (9). Sequence analysis showed this putative protein encoded by the ocfC
gene shared 94.0 % identity with the putative glycosyltransferase (Bamb_6471) of
Burkholderia ambifaria AMMD (GenBank accession number: NC_008392). There is one
conserved domain from amino acid 13 to 89 on the ocfC gene. According to the
phylogenetic tree (Fig 2.1), the OcfC putative protein of Burkholderia contaminans
MS14 is clustered with Bamb_6471 of Burkholderia ambifaria AMMD with a bootstrap
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value of 100 and both were predicted to be members of the glycosyltransferase family 25.
The Xcc-b100_0220 protein for Xanthomonas campestris pv. campestris B1 and the
PXO_04234 protein of Xanthomonas oryzae pv. oryzae PXO99A shared 55% of
similarity to OcfC.

Site-directed mutagenesis of the ocfC gene
A 1.5-kb PCR product was amplified using the primers 6471R1649 and 6471F137
(Fig. 2.2) and confirmed by sequencing to be the ocfC gene with its flanking regions. The
plasmid pKC1, which is the vector pGEM-T Easy carrying the ocfC gene, was partially
digested by restriction enzyme PstI to confirm the insertion of the ocfC fragment (Fig.
2.3). Sequencing further confirmed its identity.
A nonpolar mutation was obtained by insertion of an nptII cassette, resulting in
plasmid pKC2. The plasmid pKC2 was digested by EcoRI and PstI, which confirmed the
insertion of nptII in the plasmid (Fig. 2.4). The plasmid pKC3, which is the suicide vector
pBR325 carrying the nptII- disrupted ocfC gene, was confirmed by the EcoRI and
HindIII digestion (Fig. 2.5). Introduction of pKC3 into cells of strain MS14 resulted in
generations of the bacterial colonies with kanamycin resistance (300 µg/mL), which were
candidates of the ocfC mutants. The mutant generated via a double-crossover, named as
MS14KC1, was confirmed by PCR technique (Fig. 2.6) and sequencing.

Effect of mutation in ocfC on antifungal activity
Mutant MS14KC1 with nonpolar insertion of the nptII gene was evaluated for
occidiofungin production by inhibitory activities against the indicator fungus G.
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candidum (Fig. 2.7). MS14KC1 remained the ability to inhibit the growth of the indicator
fungus G. candidum with a reduced inhibitory zone (0.817 ± 0.022 cm). In contrast, the
antifungal activity for wild-type strain MS14 was 1.417 ± 0.056 cm in radius. The
disruption of ocfC gene caused a decrease of 42% of the antifungal activity against G.
candidum (Fig. 2.8). Based on the Fisher’s least significant difference (LSD) test, this
was a significant difference (α < 0.05). This result revealed the importance of ocfC gene
for the production of the antifungal activity of strain MS14.

Discussion
The ocfC gene encodes a member of the GT25 family of glycosyltransferases.
Glycosyltransferases are identified from various organisms and classified based on amino
acid sequence similarity (3,11). The GT25 family includes the known activities of beta1,4-galactosyltransferase and lipopolysaccharide biosynthesis protein (5). For
Haemophilus influenza, glycosyltransferase LpsA is responsible for the addition of a
hexose which can be either glucose or galactose (6). In this study, we hypothesized that
the ocfC gene codes for glycosyltransferase, which was predicted to add xylose to
oligopeptide to form occidiofungin. This is proved by the sequence analysis showing that
this putative protein encoded by ocfC gene shared 94.0 % identity to glycosyltransferase
of B. ambifaria AMMD in the phylogenetic tree generated. The known activities of the
GT25 family include beta-1, 4- galactosyltransferase, beta-1, 3- glucosyltransferase, beta1, 2 – glucosyltransferase and beta-1, 2- galactosyltransferase (CAZy database). This
study is the first evidence that xylosyltransferase is found in GT25 family. This novel
glycosyltransferase has expanded the function categories of this family. Based on the
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evidence of this study, glycosyltransferase encoded by the ocfC gene should be named
xylosyltransferase.
The ocfC gene is essential for the production of occidiofungin. The ocfC mutant
strain MS14KC1 has approximately 42% less inhibitory activity to G. candidum than the
wild-type strain. It was hypothesized that a derivative of occidiofungin produced by the
ocfC mutant MS14KC1 lacks xylose and this hypothesis was confirmed by matrixassisted laser desorption ionization (MALDI)-MS analysis (L. Smith, unpublished data).
The effect of a lack of xylose on the production of occidiofungins remains to be
investigated. In this study, a mutation of the ocfC gene results in significant reduction of
occidiofungin production based on the standard plate bioassays. However, the purified
xylose-free occidiofungin, which is produced by the mutant MS14KC1, showed higher
antifungal activity than the original occidiofungin (L. Smith, personal communication).
Therefore, we hypothesize that xylose in occidiofungin may be associated with efficient
secretion of occidiofungin by bacterial cells. In a previous work, Yethon et al. found that
mutation of the waaG gene, a glycosyltransferase gene for liposaccharide (LPS),
destabilized the outer membrane of Escherichia coli(27). It was shown that this
glycosyltransferase gene, waaG, played an important role in stabilization of the
lipopolysaccharide core protein of the outer cell membrane. Likewise, the ocfC gene
plays an important role in occidiofungin production based on the results of bioassay. In a
previous study the biosynthesis pathway of occidiofungin was proposed based on genetic
information and chemical structure of occidiofungin (9). According to this pathway, the
addition of xylose is one of the last two steps so it might be needed for translocation of
the antifungal compound across cytoplasmic membrane. However, it seems that
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antifungal activity may not require the presence of xylose. Further studies are needed to
verify these hypotheses and the resulting findings will be informative for development of
pharmaceutical drugs and biofungicides based on occidiofungin.
In conclusion, this study demonstrated that the ocfC gene encoding
glycosyltransferase is important for the production of occidiofungin. The genetic study of
the ocf gene cluster could help us understand the mechanism of the antifungal compound.
Furthermore, it was found that xylose-free occidiofungin showed higher antifungal
activity than the naturally-occuring occidiofungin. This discovery may provide us some
clues for engineering new chemical variants to have high antifungal activity and
minimize the potential toxicity to plants and animals. This might also be the key to
higher- efficiency production of occidiofungin in the pharmaceutical and agricultural
industry. Functions of a few genes in the ocf gene cluster in occidiofungin production
remain unknown and further genetic analysis of these genes will be future work to
understand biosynthesis pathway of occidiofungin.
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Table 2.1 Bacterial strains and plasmids
Strains or
plasmids
Strains
E. coli JM109

B. contaminans
MS14

Relevant Characteristics*

Sources or reference

recA1, endA1, gyrA96, thi,hsdR17,
supE44, relA1, Δ(lacproAB)/F'[traD26,
rpoAB+, laclq, lacZΔM15]

Promega

Wild type strain

(10)

MS14KC1
Plasmids

occF::nptII derivative of MS14; km

pBR325
pMLS7

Cloning vector; Cmr, Tcr, Apr
Expression vector of Burkholderia;
Tpr

pGEM-T Easy
pBSL15
pKC1
pKC2

r

r

Cloning vector; Ap
Kanamycin resistance gene cassette;
Kmr
pGEM-T Easy carrying 1.5-kb PCR
product containing the intact occF
gene; Apr
pGEM-T Easy containing 2.8-kb
occF and nptII; Kmr

This study
(18)
(12)
Promega
(1)
This study
This study

pBR325 carrying 2.8-kb EcoRI
This study
fragment containing the intact occF
gene; Kmr, Cmr, Tcr, Apr
r
*Km , kanamycin resistance; Apr, ampicillin resistance; Tpr, trimethoprim resistance;
Cmr, chloramphenicol resistance
pKC3
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Figure 2.1 Evolutionary relationships of glycosyltransferase family 25
The evolutionary history was inferred using the Minimum Evolution method (19). The
optimal tree with the sum of branch length = 6.91717329 is shown. The tree is drawn to
scale, with branch lengths in the same units as those of the evolutionary distances used to
infer the phylogenetic tree. The evolutionary distances were computed using the Poisson
correction method (28) and are in the units of the number of amino acid substitutions per
site. The ME tree was searched using the Close-Neighbor-Interchange (CNI) algorithm
(16) at a search level of 1. The Neighbor-joining algorithm was used to generate the
initial tree. All positions containing gaps and missing data were eliminated from the
dataset (Complete deletion option). There were a total of 218 positions in the final
dataset. Phylogenetic analyses were conducted in MEGA4 (22). (Bamb_6471 for
Burkholderia ambifaria AMMD; OcfC for Burkholderia contaminans MS14; Xccb100_0220 for Xanthomonas campetris pv. campestris B100; PXO_04234 for
Xanthomonas oryzae pv. oryzae PX099A; Ecolc_3376 for Escherichia coli ATCC
8379; Arad_3667 for Agrobacterium radiobacter K84; MCA1423 for Methylococcus
capsulatus str. Bath)
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Figure 2.2 PCR amplification of the ocfC gene with its flanking regions
DNA marker (BenchTop 1-kb DNA ladder, Promega) is in lane M. 1.5-kb ocfC gene with
its flanking region is in lane 1, and negative control is in lane 2.
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Figure 2.3 Partial digestion of plasmid pKC1
DNA marker (BenchTop 1-kb DNA ladder, Promega) is in lane M. Partial digestion with
PstI of pKC1 is in lane 1(pGEM T-Easy::ocfC is 4.5-kb, partial digestion of pGEM TEasy::ocfC is 3.9-kb, and there is a small and weak band for 0.7-kb).
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Figure 2.4 Restriction enzyme digestion to confirm plasmid pKC2
DNA marker (BenchTop 1-kb DNA ladder, Promega) is in lane M. pKC2 digested with
EcoRI is in lane 1 (pGEM-T Easy vector is 3-kb, and ocfC ::nptII is 2.8-kb). pKC2
digested with PstI is in lane 2 (pGEM-T Easy and part of ocfC ::nptII is 3.8-kb). The
nptII is 1.3-kb. Part of ocfC::nptII is 0.7-kb). pKC2 digested with EcoRI and PstI is in
lane 3 (pGEM-T Easy is 3-kb. The nptII is 1.3-kb. Part of pGEM-T Easy and ocfC::nptII
is 1-kb. Part of ocfC::nptII is 0.7-kb). The nptII gene is in lane 4.
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Figure 2.5 Restriction enzyme digestion to confirm plasmid pKC3
DNA marker (BenchTop 1-kb DNA ladder, Promega) is in lane M; pKC3 digested with
EcoRI and HindIII is in lane 1. The size of pBR325 is 6-kb and ocfC::nptII is 2.8-kb.
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Figure 2.6 PCR analysis to confirm the identity of the ocfC mutant
DNA marker (1-kb DNA step ladder, Promega) is in lane M, 1.5-kb ocfC gene is in lane
1, 2.8-kb ocfC::nptII gene is in lane 2, and negative control is in lane 3.
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Figure 2.7 Plates bioassays for antifungal activities of Burkholderia contaminans against
indicator fungus Geotrichum candidum
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Figure 2.8 Relative inhibition of production of occidiofungin by Burkholderia
contaminans strain MS14 and its mutant MS14KC1
The strains were inoculated on potato dextrose agar, incubated at 28°C for 4 days and
then over-sprayed with Geotrichum candidum. Difference between treatments was tested
by Fisher’s least significant difference (LSD) test. Vertical bars were standard error of
mean.
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CHAPTER III
OPTIMIZATION OF MEDIUM COMPONENTS AND CULTURE CONDITIONS FOR
OCCIDIOFUNGIN PRODUCTION BY BURKHOLDERIA CONTAMINANS
STRAIN MS14

Abstract
Occidiofungin produced by Burkholderia contaminans MS14 is an antifungal
compound with potential for future bio-control applications. In order to obtain high yields
of this antifungal compound it is necessary to have suitable cultural conditions and
medium components. This study presents the effects on occidiofungin production of
different medium components such as amino acids, carbon sources, metal ions and
nitrogen sources as well as pH values in solid medium. The results of optimization of
cultural conditions indicate increased inoculation cell density (20% culture volume)
produces the highest amount of occidiofungin. Addition of casamino acid enhanced the
antifungal activity by 32%. Supplementation of xylose as a carbon source produced the
best antifungal activity. Urea was the best nitrogen source and zinc promoted production
of occidiofungin. In addition, an acidic environment (pH5) was better for the antifungal
compound production. These preliminary data provide a foundation for further
optimization of occidiofungin production.
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Introduction
Occidiofungin, a glycolipopeptide, shows a broad range of antifungal activities
against plant and animal pathogens (7). It is produced by Burkholderia contaminans
strain MS14 that was isolated from disease-suppressive soil (8). A 56-kb genomic DNA
fragment, named the ocf gene cluster, harboring 16 open reading frames (ORFs) was
identified (4). Of the 16 ORFs, the genes encoding biosynthetases and LuxR regulators
(ambR1 and ambR2) have been characterized (5, 6). The backbone of occidiofungins is
composed of eight amino acids with a xylose and it has four variants: variants A, B, C,
and D. Variants A and B were both composed by eight amino acids (4). The only
difference between A and B variants is an addition of oxygen on asparagine to form
occidiofungin B (4).Variant C has an addition of oxygen on asparagine to form
occidiofungin D. The variant C contains beta- hydroxy modification of tyrosine;
however, there is a 3-chloro addition to beta- hydroxytyrosine (4).
Production of bacterial secondary metabolites can be promoted by optimization of
culture conditions and culture medium compositions. Lantibiotic mutacin production
was increased more than 100-fold on an optimized culture medium (1). Cyclosporin A
produced by Tolypocladium inflatum was optimized from 792 mg/kg to 6,480 mg/kg by
using solid state fermentation (10). Optimization of media components and culture
condition for the production of occidiofungin has not been studied yet. Current data
showed that the yield of occidiofungin is about 100-500 µg/L. This study focuses on
optimization of occidiofungin produced by Burkholderia contaminans strain MS14
through changing the components of Burkholderia minimal media (14). Different
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components such as amino acids, carbon sources, nitrogen sources, inorganic salts, and
pH values were investigated in this study in order to increase yield of occidiofungin.

Materials and methods

Bacterial strains and media
B. contaminans MS14 was routinely grown was on nutrient broth-yeast extract
(NBY) agar medium (12) at 28°C . Potato dextrose agar (PDA) (Difco, Detroit, MI) and
Burkholderia minimum media (BM) (14) were used for bioassay of B. contaminans
MS14 for antifungal activities.

Liquid bioassay
Spore suspension of Geotrichum candidum F-260 (3) was prepared to 0.3 O.D420.
The culture extract was serially diluted using the BM medium. B. contaminans strain
MS14 was streaked out from glycerol stock on a NBY plate. Single colonies were used to
inoculate into 100 mL BM and cultured at 28°C for 4 days without shaking. Bacterial
cells were collected by centrifugation for 4 min at 5000 g. The supernatant of BM media
was used for evaluation of occidiofungin activity. The culture extract was mixed with the
G. candidum spore suspension to 0.3 OD420. The mixture was incubated at 28oC
overnight. Snowflake- like G. candidum hyphae were visible macroscopically if there was
no antifungal activity (6).
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Plate bioassay
Strain MS14 was cultured overnight in NBY liquid medium and bacterial cells
were harvested by centrifuge. The cell suspension was adjusted to 0.3 O.D420. MS14
suspension (5µl) was dropped onto the center of BM media and the plates were incubated
at 28°C for 4 days. Spore suspension of G. candidum was adjusted into 0.3 OD420 and was
oversprayed onto the media. Sprayed plates were incubated at 28°C overnight (6). The
radius of the inhibitory zone was used for evaluating antifungal activities.

Effect of inoculation cell density
Initial inoculations of 1, 5, 10, and 20 ml of MS14 suspension at 0.3 OD420 were
placed in 80 ml liquid BM medium. Samples (1 ml for each) were taken at a 12-hour
interval after two days to evaluate antifungal activity using the liquid bioassay method
described previously. Bacterial cells were collected by centrifugation for 4 min at 5000 g.
The supernatant of BM medium was used for evaluation of occidiofungin activity. The
culture extract was serially diluted in to final concentrations of 1/2, 1/4, 1/8, 1/16 and
1/32 of original culture extract. Spore suspension of G. candidum was prepared to 0.3
O.D420. The diluted culture mix and spore suspension were combined and placed at 28°C
overnight without shaking. Three replicates for the liquid bioassay were performed
independently.

Effects of amino acids
Effects of amino acids on antifungal compound production were evaluated.
Asparagine (Asn), glycine (Gly), lysine (Lys), serine (Ser), tryptophan (Typ), and
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tyrosine (Tyr) were individually added to BM media, respectively, to a final concentration
of 20 mM for each amino acid. Furthermore, casamino acid was also added to the BM at
a final concentration at 4g/L. Three replicates for the plate bioassay were performed
independently.

Effects of carbon sources
Effects of glucose, galactose, lactose, mannose and xylose on the production of
occidiofungin were examined. The final concentrations of these carbon sources in the BM
media were 22.2 mM. These carbon sources were sterilized separately and aseptically
added to the sterilized BM medium. Three replicates for the plate bioassay were
performed independently.

Effects of metal ions
Effects of different metal ions on occidiofungin production were investigated
using MgSO4, ZnCl2, MnSO4, MnCl2, CaCl2, and FeCl3. These were added in BM to a
final concentration of 10 mM. Three replicates for the plate bioassay were conducted
independently.

Effects of nitrogen sources
Effects of ammonium chloride, ammonium sulfate, sodium nitrate and urea on
production of occidiofungin were tested. These nitrogen sources were added to BM
medium to a final concentration of 20 mM. Three replicates for the plate bioassay were
performed independently.
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Effects of pH values
Effects of pH values of media on occidiofungin activity were tested with different
pH values as follows: pH 4, 5, 6, 7, 8, 9 and 10. The pH values of BM were adjusted with
1N sodium hydroxide (NaOH) or 1N hydrogen chloride (HCl). Three replicates for the
plate bioassay were performed independently.

Results and Discussion

Effect of optimal inoculation cell density
The fermentation solution of MS14 was collected every twelve hours from day 2
to 6. As expected, greater initial inoculum resulted in earlier production of the antifungal
compound (Fig. 3.1). When the amount of initial inoculum was higher, the metabolites
produced by MS14 were higher in the limited nutrient conditions. No significant
differences were found for initial 1 and 5ml inoculum levels.

Effects of optimal amino acids
Twenty amino acids could be tested for the effect of occidiofungin production.
However, the previously determined structure of occidiofungin indicates that only Asn,
Gly, Lys, Ser, Typ, and Tyr are present in this compound (7). These six amino acids and
casamino acid, a mixture of amino acids, were tested in this study. There was no
difference in the production of antifungal compound between the six individual amino
acids (Fig. 3.2). Based on previous study, additional casamino acid could enhance the
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production of the syringomycin (3). Interestingly, according to Fisher’s least significant
difference (LSD) test, adding casamino acid in the BM media could enhance the
production of antifungal compound. For the production of occidiofungin, all six amino
acids are needed. This might explain why single amino acids caused relatively lower
production of the antifungal compound than the production when casamino acid was
added. Therefore, casamino acid resulted in a greater amount of the occidiofungin
production.

Effects of optimal carbon sources
In the BM medium, 0.02M glucose is used as carbon source. Two experiments
were conducted to see if the glucose concentration and glucose are the optimal carbon
source for the antifungal compound production. First, different concentrations of glucose
were tested (Fig. 3.3). Based on the LSD t-test statistical analysis, 1 g/L concentration of
glucose produced relatively high yields of antifungal compound. Second, some
monosaccharide and disaccharide sugars were examined in order to find the optimal
carbon sources. Glucose, galactose, lactose, mannose and xylose were tested at
concentration of 0.02M. PDA was used as a control. Of all the carbon sources tested,
xylose increased the production of antifungal compound compared with glucose,
galactose, lactose and mannose (Fig. 3.4). In fact, the bacteria Burkholderia spp. can
utilize the xylose as a sole carbon source (11). More importantly, xylose is required for
biosynthesis of occidiofungin (7).
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Effects of optimal metal ions
In this study, 10mM CaCl2, FeCl3, MgSO4, MnCl2, MnSO4, and ZnCl2 were
examined (Fig. 3.5). Fisher’s LSD test was used to do data analysis. Calcium was no
better than magnesium and manganese. In a previous study, the yield of bacitracin
produced by Bacillus licheniformis was increased by adding magnesium, and manganese
(2). Magnesium ions are essential in various kinds of enzyme reactions in the production
of bacterial metabolites (1). However, in the current study the addition of magnesium did
not result in as great a production of the antifungal agent as did some other metal ions.
The addition of manganese also produced no differences compared to the other metal ions
tested. The addition of ferric ions resulted in a lack of growth of the indicator fungus. It
might result in inhibition of the growth of the fungus at the tested concentration of ferric
ion. The addition of zinc ions resulted in the greatest antifungal production among the
metal ions tested. Zinc is important for the production of some antibiotics such as
lantibiotics (1), so zinc may be important for the enzymatic modification of
occidiofungin. However, further studies are needed to understand the role of zinc in
occidiofungin.

Effects of optimal nitrogen sources
The nitrogen source in BM media is ammonium sulfate. Several nitrogen sources
were tested at 0.02M such as ammonium chloride, sodium nitrate and urea. Ammonium
nitrogen present in liquid manure resulted in a significantly increased production of
polyamino acids produced by Bacillus strain (9). For cyclosporine produced by
Tolypocladium inflatum, additional ammonium sulfate resulted in the maximum
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production. For the Myrothecium verrucaria, the chitinase production was enhanced in
the presence of urea (13). In this study, nitrogen sources such as ammonium sulfate,
ammonium chloride, and sodium nitrate produced low antifungal compound production.
Therefore, the production of antifungal compound was significantly enhanced only by
addition of urea base on Fisher’s LSD analysis (Fig. 3.6).

Effects of optimal pH values
The optimal pH is 5 for production of lactocin, a bacteriocin produced by
Lactobacillus rhamnosus (1). In this study, pH 4, 5, 6, 7, 8, 9, and 10 were tested. B.
contaminans MS14 did not grow on the media having pH 4 and 10. In general, the yield
of antifungal compound is higher in acidic and neutral (pH 5, 6 and 7) than in basic (pH 8
and 9) environments (Fig.3.7) based on Fisher’s LSD test.

Effect of casamino acid at pH 5 and 6
For all of the tested factors, the addition of casamino acid significantly increased
occidiofungin production as compared to the other amino acids tested. For pH values, the
acidic condition resulted in higher occidiofungin production. These two factors were
investigated together. Casamino acid in pH 5 and 6 were examined with 2.5, 5, 10, and 20
g/L of casamino acid tested at each pH (Fig.3.8 and 3.9, respectively). BM medium at
pH 7 with no casamino acid was the control. At pH 5 there is no difference between each
concentration of casamino acid. However, additional casamino acid in BM media in pH 6
produced relatively higher yields of occidiofungin.
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Conclusions
In this study, production of occidiofungin by strain MS14 was optimized in liquid
BM medium by inoculation cell density and in plate bioassay with regulated amino acids,
carbon sources, metal ions, nitrogen sources and pH values. Our data show that
optimized individual conditions for the production of occidiofungin are higher
inoculation cell density (20% culture volume), additional casamino acid (32% increase),
xylose (22%), urea (13%), zinc ions (18%), and pH 5 (10%). For further study, two or
more factors should be combined for optimization of occidiofungin production.
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Figure 3.1 Effect of inoculation cell density on antifungal activity
1, 5, 10, 20 ml of MS14 solution were used for initial inoculation. The culture extract was
serially diluted in the final concentration of 1/2, 1/4, 1/8, 1/16 and 1/32 of original culture
extract for every 12 hour. Spore suspension of Geotrichum candidum (GC) was prepared
to 0.3 O.D420. Culture extract and spore suspension were mixed overnight without
shaking to observe the antifungal activity. Expo trend means exponential trend line for
that treatment.
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Figure 3.2 Optimization of occidiofungin production using amino acids
Concentration of each amino acid is 0.02M. Differences between treatments are
determined by Fisher’s least significant difference (LSD) test. Different letters for each
treatment indicate statistically significant difference. Mean values for three biological
replicates are given and error bars represent the standard errors of the mean.
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Figure 3.3 Optimization of occidiofungin production using different concentrations of
glucose
Glucose concentrations are ranging from 0.5 to 8 g/L. Differences between treatments are
determined by Fisher’s least significant difference (LSD) test. Different letters for each
treatment indicate statistically significant difference. Mean values for three biological
replicates are given and error bars indicate the standard errors of the mean.
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Figure 3.4 Optimization of occidiofungin production for carbon sources
Concentration of each carbon source is 0.02M. Differences between treatments are
determined by Fisher’s least significant difference (LSD) test. Different letters for each
treatment indicate statistically significant difference. Mean values for three biological
replicates are given and error bars indicate the standard errors of the mean.
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Figure 3.5 Optimization of occidiofungin production using metal ions
Concentration of each metal ion is 0.01M. Differences between treatments are determined
by Fisher’s least significant difference (LSD) test. Different letters for each treatment
indicate statistically significant difference. Mean values for three biological replicates are
given and error bars indicate the standard errors of the mean.
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Figure 3.6 Optimization of occidiofungin production using various nitrogen sources
Concentration of each nitrogen source is 0.02M. Differences between treatments are
determined by Fisher’s least significant difference (LSD) test. Different letters for each
treatment indicate statistically significant difference. Mean values for three biological
replicates are given and error bars indicate the standard errors of the mean.
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Figure 3.7 Optimization of occidiofungin production for pH ranging from pH 5 to 9
Differences between treatments are determined by Fisher’s least significant difference
(LSD) test. Different letters for each treatment indicate statistically significant difference.
Mean values for three biological replicates are given and error bars indicate the standard
errors of the mean.
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Figure 3.8 Optimization of occidiofungin production for casamino acid concentration
ranging from 2.5 to 20g/L at pH 5
Differences between treatments are determined by Fisher’s least significant difference
(LSD) test. Different letters for each treatment indicate statistically significant difference.
Mean values for three biological replicates are given and error bars represent the standard
errors of the mean.
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Figure 3.9 Optimization of occidiofungin production for casamino acid concentration
ranging from 2.5 to 20g/L at pH 6
Differences between treatments are determined by Fisher’s least significant difference
(LSD) test. Different letters for each treatment indicate statistically significant difference.
Mean values for three biological replicates are given, and error bars are the standard
errors of the mean.

53

References

1. Dahal, N., N. Chaney, D. Ellis, S. E. Lu, and L. Smith. 2010. Optimization of
the production of the lantibiotic mutacin 1140 in minimal media. Process
Biochem. 45:1187-1191.
2. Frøyshov, O. and A. Mathiesen. 1979. Tryptic cleavage of enzyme A in
bacitracin synthetase. FEBS Lett. 106:275-278.
3. Gross, D. C. and J. E. DeVay. 1977. Production and purification of
syringomycin, a phytotoxin produced by Pseudomonas syringae. Physiol. Plant
Pathol. 11:13-28.
4. Gu, G., L. Smith, A. Liu, and S. E. Lu. 2011. A genetic and biochemical map for
the biosynthesis of occidiofungin, an antifungal produced by Burkholderia
contaminans strain MS14. J. Appl. Environ. Microbio. 77:6189-6198.
5. Gu, G., L. Smith, N. Wang, H. Wang, and S.-E. Lu. 2009. Biosynthesis of an
antifungal oligopeptide in Burkholderia contaminans strain MS14. Biochem.
Biophys. Res. Commun. 380:328-332.
6. Gu, G., N. Wang, N. Chaney, L. Smith, and S. E. Lu. 2009. AmbR1 is a key
transcriptional regulator for production of antifungal activity of Burkholderia
contaminans strain MS14. FEMS Microbiol. Lett. 297:54-60.
7. Lu, S. E., J. Novak, F. W. Austin, G. Gu, D. Ellis, M. Kirk, S. WilsonStanford, M. Tonelli, and L. Smith. 2009. Occidiofungin, a unique antifungal
glycopeptide produced by a strain of Burkholderia contaminans. Biochemistry
48:8312-8321.
8. Lu, S.-E., S. Woolfolk, and J. Caceres. 2005. Isolation and identification and
genetic analysis of rhizobacteria antagonistic to plant soilborne fungal pathogens.
Phytopathology 95:62-63.
9. Pötter, M., F. B. Oppermann-Sanio, and A. Steinbüchel. 2001. Cultivation of
bacteria producing polyamino acids with liquid manure as carbon and nitrogen
source. Appl Environ Microbiol. 67:617-622.
10. Survase, S. A., N. S. Shaligram, R. C. Pansuriya, U. S. Annapure, and R. S.
54

Singhal. 2009. A novel medium for the enhanced production of Cyclosporin A by
Tolypocladium inflatum MTCC 557 using solid state fermentation. J. of
Microbiol. and Biotechnol. 19:462-467.
11. Vanlaere, E., A. Baldwin, D. Gevers, D. Henry, E. De Brandt, J. J. Lipuma, E.
Mahenthiralingam, D. P. Speert, C. Dowson, and P. Vandamme. 2009. Taxon
K, a complex within the Burkholderia cepacia complex, comprises at least two
novel species, Burkholderia contaminans sp nov and Burkholderia lata sp nov.
Int. J. of Syst. and Evol. Microbiol. 59:102-111.
12. Vidaver, A. K. 1967. Synthetic and complex media for the rapid detection of
fluorescence of phytopathogenic pseudomonads: Effect of the carbon source.
Appl. Microbiol. 15:1523-1524.
13. Vyas, P. and M. V. Desphpande. 1989. Chitinase production by Myrothecium
verrucaria and its significance for fungal mycelia degradation. J Gen Appl
Microbiol. 35:343-350.
14. West, T. P. 2000. Role of cytosine deaminase and beta-alanine-pyruvate
transaminase in pyrimidine base catabolism by Burkholderia cepacia. Antonie
Van Leeuwenhoek 77:1-5.

55

